PRIMARY IGA NEPHROPATHY
Clinical trials for PRIMARY IGA NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new PRIMARY IGA NEPHROPATHY trials appear
Sign up with your email to follow new studies for PRIMARY IGA NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kidney disease: experimental drug targets root cause of IgA nephropathy
Disease control Recruiting nowThis study tests a new drug, sefaxersen, in about 428 adults with IgA nephropathy, a kidney disease that can lead to kidney failure. Participants must have a high risk of their disease getting worse despite standard care. The drug aims to reduce protein in the urine and slow kidn…
Matched conditions: PRIMARY IGA NEPHROPATHY
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 03:57 UTC
-
New drug YKST02 aims to tame kidney disease in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called YKST02 in 12 adults with IgA nephropathy, a kidney disease. The main goal is to see if the drug is safe and if it can reduce protein in the urine, a sign of kidney damage. Participants receive the drug by IV and are closely monitored…
Matched conditions: PRIMARY IGA NEPHROPATHY
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 26, 2026 03:50 UTC
-
New hope for kidney disease patients: long-term iptacopan safety trial now recruiting
Disease control Recruiting nowThis study looks at the long-term safety of a drug called iptacopan in adults with primary IgA nephropathy, a kidney disease. Participants must have completed a previous iptacopan study. They will receive the drug openly (everyone knows they are getting it) until it becomes comme…
Matched conditions: PRIMARY IGA NEPHROPATHY
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 14:03 UTC